2018
DOI: 10.1097/sla.0000000000002115
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer

Abstract: The SIS is a novel prognostic factor in CRC patients. Additionally, the SIS is an alternative inflammation-based biomarker, which may improve the prediction of clinical outcomes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
108
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 110 publications
(117 citation statements)
references
References 24 publications
2
108
0
Order By: Relevance
“…Most frequently evaluated prognostic factors include those directly associated to the neoplasm per se, that is, morphologic, proteomic, genomic or epigenomic, while the patient's immune and nutritional status have been often overlooked . There is an increasing evidence that systemic inflammation plays a critical role in carcinogenesis and the invasion or metastatic processes in CRC . The tumor‐associated inflammatory response has been recognized to exert a contradictory effect, enhancing tumorigenesis and progression, and actually aiding incipient neoplasms to acquire hallmark capabilities .…”
Section: Discussionmentioning
confidence: 99%
“…Most frequently evaluated prognostic factors include those directly associated to the neoplasm per se, that is, morphologic, proteomic, genomic or epigenomic, while the patient's immune and nutritional status have been often overlooked . There is an increasing evidence that systemic inflammation plays a critical role in carcinogenesis and the invasion or metastatic processes in CRC . The tumor‐associated inflammatory response has been recognized to exert a contradictory effect, enhancing tumorigenesis and progression, and actually aiding incipient neoplasms to acquire hallmark capabilities .…”
Section: Discussionmentioning
confidence: 99%
“…The clinical utility of new diagnostic markers of malignancies must be evaluated to identify potentially useful methods for prognosis and treatment monitoring. In recent years, accumulating evidence has elucidated the role of inflammation-based prognostic scores, including PNI, NLR, PLR, PI, mGPS and GPS in cancer patient prognosis (12)(13)(14)(15). Although several studies have identified CAR as a prognostic factor for patients with various types of tumors (6)(7)(8), the prognostic value in patients with ESCC remained unclear (16).…”
Section: Discussionmentioning
confidence: 99%
“…1 a). The mGPS scores were calculated by assigning a score of 2 to patients with elevated serum CRP levels (>0.5 mg/dL) and decreased serum albumin levels (<3.5 g/dL), by assigning a score of 1 to patients with one abnormal value, and by assigning a score of 0 to patients with no abnormal values [14] . The PNI was calculated as 10 × serum albumin (g/dL) + 0.005 × total lymphocyte count (per mm 3 ) [19] .…”
Section: Measurements Of Inflammation-and Nutrition-based Markersmentioning
confidence: 99%
“…Systemic inflammation in cases of malignancy is characterized by an imbalance between pro-and anti-inflammatory cytokines, and inflammatory markers can be used to predict prognosis in various malignancies. For example, the prognostic markers for urogenital cancer and multiple myeloma include elevated values for C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and the Glasgow Prognostic Score (GPS) [4,9,13,14] . Moreover, several reports have indicated that systemic inflammation plays a critical role in the pathogenesis of malnutrition, weight loss, and muscle loss in cachexia cases [15][16][17][18] .…”
mentioning
confidence: 99%